Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

32 results about "Piperlongumine" patented technology

Piperlongumine (PL) is a natural product constituent of the fruit of the Long pepper (Piper longum), a pepper plant found in southern India and southeast Asia. Piperlongumine may have anti-cancer properties. In in vitro experiments, it selectively kills some types cancer cells over normal cells. One study in a xenograft mouse model of cancer showed that piperlongumine inhibits the growth of malignant breast tumors and their associated metastases. Although this study has been retracted . Its anticancer effects may be due to silencing the GSTP1 gene. Piperlongumine inhibits the migration of breast cancer cells (MDA-MB-231), an approach for discovering antimetastatic agents.

Method for synthesizing piperlongumine compounds

The invention provides a method for synthesizing piperlongumine compounds, wherein the compounds are coupled by adopting acromatic carboxylic acid and amido compounds in the presence of coupling reagent. The method has the advantages of mild reaction condition and simple and convenient operation method, and is suitable for batch production of the compounds.
Owner:BEIJING OKEANOS TECH

Piperlongumine-ligustrazine heterocomplex, preparation method and medical application

The invention discloses a piperlongumine-ligustrazine heterocomplex, a preparation method and a medical application. The piperlongumine-ligustrazine heterocomplex is a compound, isomer or pharmaceutically acceptable salt as shown in the specific formula (I), wherein R1, R3 or R4 is independently selected from C1-3 alkyl groups or C1-3 alkoxygroups; R2 is selected from the hydrogen (H) or halogen. The compound has good water solubility, is higher in proliferation inhibition activity for 4 colon cancer cells than that of piperlongumine. The compound, the isomer or the pharmaceutically acceptable salt can be applied to respects of medicines for treating or preventing tumors, or applies to respects of medicines relevant to metastatic cancer, and can be applied to relevant diseases including but not limited to brain gliomas, colon cancer, metastatic colon cancer, cell lung cancer, myoblastosis and the like.
Owner:CHINA PHARM UNIV

Compound medicine composition with anti lymphoma activity and use thereof

The present invention belongs to the field of natural medicines and discloses a compound medicine composition with anti lymphoma activity containing piperlongumine and houttugnin and use thereof. Active ingredients of the compound medicine composition comprise the piperlongumine and the houttugnin in a molar ratio of 1:1 to 1:20. Through combination of the piperlongumine and the houttugnin, the compound medicine composition has a strong synergistic treatment effect on lymphoma.
Owner:FOSHAN UNIVERSITY

Application of nitrogen mustard based piperlongumine compound in medicine

The invention provides application of a nitrogen mustard based piperlongumine compound in medicine. On the basis of the research on the nitrogen mustard based piperlongumine compound for inhibiting the activity of malignant cells, it proves that the nitrogen mustard based piperlongumine compound has the good anti-tumor activity, and a new choice is provided for preparing anti-tumor medicine.
Owner:广东永纯医药集团有限责任公司

Compound medicine composition with lung cancer resistant effect and application of compound medicine composition

The invention belongs to the field of natural medicine, and discloses a compound medicine composition with a lung cancer resistant effect and application of the compound medicine composition. Active ingredients of the compound medicine composition consist of piperlongumine and rheum emodin in a molar ratio of (1:1) to (1:10). By combining the piperlongumine and rheum emodin, a synergic effect for treating the lung cancer is relatively good.
Owner:佛山市第五人民医院 +1

Application of piperlongumine in preparation of medicine for preventing and treating immunological rejection in corneal transplantation

InactiveCN113244233AAlleviate immune rejection of transplantProlong survival timeOrganic active ingredientsSenses disorderOphthalmologyCytokine
The invention relates to application of piperlongumine in preparation of a medicine for preventing and treating immunological rejection in corneal transplantation. Researches prove that the natural compound piperlongumine can effectively relieve immunological rejection in corneal transplantation and prolong the survival time of the corneal graft in a transplant rejection animal model, and possible mechanisms comprise inhibition of generation of immune cells and local infiltration and reduction of secretion of related inflammatory cytokines. The invention proves the effectiveness of the natural compound piperlongumine in treating the immunological rejection after the corneal transplantation, and shows that the piperlongumine has great development potential and research value when being used as a new anti-rejection medicine after the corneal transplantation.
Owner:EYE & ENT HOSPITAL SHANGHAI MEDICAL SCHOOL FUDAN UNIV

Compound medicinal composition having function of treating Alzheimer's disease and application of compound medicinal composition

The invention belongs to the field of natural medicines, and discloses a compound medicinal composition having a function of treating Alzheimer's disease and an application of the compound medicinal composition. An active ingredient of the compound medicinal composition consists of piperlongumine and lycopene at the mass ratio of 1: (10-500). The compound medicinal composition, on the basis of a synergistic effect between the piperlongumine and the lycopene under certain dosages, is capable of treating the Alzheimer's disease.
Owner:佛山市第五人民医院 +2

Purposes of piperlongumine used for preparing medicine preventing cerebral arterial thrombosis

The invention relates to the medical technology field, and provides purposes of piperlongumine used for preparing a medicine preventing cerebral arterial thrombosis. Through pharmacological test of a mouse focal cerebral ischemia model, the facts are discovered that piperlongumine can improve behavior symptoms caused by mouse cerebral ischemia reperfusion injury obviously, the cerebral infarction size is reduced, and encephaledema degree of a mouse with cerebral ischemia is lowered. Thus piperlongumine can be used for preparing a medicine preventing cerebral arterial thrombosis.
Owner:SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY

Application of piperlongumine in inhibition of NLRP3 inflammasome activation

The invention discloses an application of piperlongumine in inhibition of NLRP3 inflammasome activation. It is found that piperlongumine can inhibit NLRP3 inflammasome activation induced by nigericin in mouse macrophages and human mononuclear macrophages, in addition, piperlongumine not only can inhibit classical NLRP3 inflammasome activation caused by nigericin, urate crystals, aluminum and other different NLRP3 inflammasome activators, but also can inhibit activation of non-classical NLRP3 inflammasome caused by intracellular LPS, can relieve peritonitis induced by urate crystallization, and can be used for treating NLRP3 inflammasome-related inflammatory diseases such as type II diabetes atherosclerosis, gout, rheumatic arthritis, rheumatoid arthritis and the like. The invention provides an effective way for treating Parkinson's multiple sclerosis, Alzheimer's disease and the like.
Owner:SOUTH CHINA UNIV OF TECH

Hypoglycemic application of piperlongumine alkaloids

The invention relates to a hypoglycemic application of piperlongumine alkaloids. The piperlongumine alkaloids comprise retrofractamide B and guineensine, in vitro alpha-glucosidase activity determination are performed on retrofractamide B and guineensine, results show that retrofractamide B and guineensine in the piperlongumine alkaloids have relatively good inhibitory effect on alpha-glucosidaseactivity and can be used for preparing drugs for treating diabetes, and a favorable material basis is provided for development of piperlongumine alkaloid drugs for treating diabetes.
Owner:XINJIANG TECHN INST OF PHYSICS & CHEM CHINESE ACAD OF SCI

Dental pulp stem cell culture medium and culture method

The dental pulp stem cell culture medium comprises a basic culture medium and the following components added in the basic culture medium: ajuga decumbens sugar, opal micro powder, sodium selenite, L-glutathione, piperlongumine, magnolol, bFGF, zinc citrate and beta-sodium glycerophosphate. According to the culture medium provided by the invention, the decumbent bugle herb sugar and the opal micro powder are added; on one hand, the decumbent bugle herb sugar contributes to uniform distribution of the opal micro powder; on the other hand, with the opal micro powder, the adherence of the dental pulp stem cells is improved, the adherence time of the cells is shortened, and the proliferation efficiency of the dental pulp stem cells is improved. Piperlongumine and magnolol are added, so that the probability that the dental pulp stem cells are polluted by infectious microbes in the culture process is reduced, cell apoptosis and slow cell growth caused by the infectious microbes are avoided, and the service time of the culture medium can be prolonged. The invention further provides a culture method of the dental pulp stem cells, the culture medium is adopted, components are safe and clear, and the proliferation efficiency of the dental pulp stem cells is effectively improved.
Owner:李保建

Application of piperlongumine in preventing and treating plant pathogenic fungi

ActiveCN113826629AEnhanced inhibitory effectGive full play to the application valueBiocideFungicidesBiotechnologyPiperlongumine
The invention provides application of piperlongumine in preventing and treating the plant pathogenic fungi. The test concentration of the piperlongumine serving as a bactericide for preventing and treating the plant pathogenic fungi is larger than or equal to 200 mg / L; as an antibacterial active component, the piperlongumine can be used for preventing and treating fusarium wilt, botrytis cinerea, gibberellic disease, physalospora piricola, alternaria alternata, peronophythora, northern leaf blight and corynespora fallen leaf, the inhibition rate is 80% or above, and meanwhile, the piperlongumine also has relatively strong protection and treatment effects on botrytis cinerea. Tests show that the piperlongumine has a broad-spectrum bactericidal effect on plant pathogenic fungi, and a foundation is laid for further utilizing piperaceae plant piper longum to create a novel botanical fungicide.
Owner:ENVIRONMENT & PLANT PROTECTION INST CHINESE ACADEMY OF TROPICAL AGRI SCI

Application of Nitrogen mustardyl perylene amide compounds in medicine

The invention provides application of a nitrogen mustard based piperlongumine compound in medicine. On the basis of the research on the nitrogen mustard based piperlongumine compound for inhibiting the activity of malignant cells, it proves that the nitrogen mustard based piperlongumine compound has the good anti-tumor activity, and a new choice is provided for preparing anti-tumor medicine.
Owner:广东永纯医药集团有限责任公司

Use of resveratrol-based perylene amide analogs in medicine

The invention provides application of a resveratrol group containing piperlongumine analogue in medicine. The structure of the resveratrol-group piperlongumine analogue is as shown in figure (I), and the analogue is obtained on the basis of a great amount of activity screening; the analogue is good in antineoplastic activity; therefore, a new choice is provided for the development and the application of antineoplastic drugs.
Owner:杭州世子合德生物科技有限公司

NO donor type piperlongumine derivative as well as preparation method and application thereof

The invention belongs to the technical field of medicinal chemistry, and particularly relates to NO donor type piperlongumine derivatives as well as a preparation method and application thereof. The derivative provided by the invention is specifically a compound as shown in a formula (I), an isomer or pharmaceutically acceptable salt thereof, wherein R1 is selected from morpholine, pyrazine, pyrrole, furan, pyridine, quinoline, thiophene, diethylamine and derivative structures related to the morpholine, pyrazine, pyrrole, furan, pyridine, quinoline, thiophene, diethylamine and the like. R2 is selected from H or halogen. The compound, the isomer or the pharmaceutically acceptable salt of the compound can be applied to preparation of anti-tumor drugs for treatment or prevention, and particularly has good application prospects in treatment or prevention of colon cancer and non-small cell lung cancer.
Owner:WUHAN UNIV OF SCI & TECH

Method for preparing albumin nanoparticles and freeze-dried powder of piperlongumine

The invention discloses a method for preparing albumin nanoparticles and freeze-dried powder of piperlongumine and belongs to the technical field of medicine. The method includes: dissolving the raw material medicine of piperlongumine in an appropriate amount of an organic solvent as an organic phase; dissolving bovine serum albumin in pure water as a water phase; slowly dripping the organic phaseinto the water phase under the action of high speed shear, and performing shear dispersion to obtain colostrum; transferring the colostrum to a high pressure micro-jet nano-dispersion instrument to be homogenized at appropriate pressure; after homogenization, removing the organic solvent by rotating evaporation to obtain albumin nanoparticles of the piperlongumine, and freeze drying the albumin nanoparticles to obtain the albumin freeze-dried powder of the piperlongumine. The albumin nanoparticles of the piperlongumine can improve water solubility of the piperlongumine and improve the bioavailability of the medicine; the preparation process is simple, the use of glutaraldehyde is avoided, and good safety is achieved.
Owner:LIAONING UNIVERSITY

Derivatives of piperlongumine and uses thereof

The present invention relates to a group of 1-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-2,3-dihydropyridin-6-one (piperlongumine) derivatives, analogs and pharmaceutically acceptable salts thereof. The present invention also relates to processes for preparing the same; a pharmaceutical composition and formulation containing a derivative of piperlogumine; and use of the derivatives and analogs for treating cancer.
Owner:AURANSA INC

A personal care composition comprising piperlongumine and process for producing the composition

A process for producing a personal care composition comprising piperlongumine the process comprising the following steps: i) adding piperlongumine to a polyol or a polyol mixture comprising less than 5 wt% of the polyol mixture of water, to form a piperlongumine pre-mix in the form of a suspension or solution; ii) adding the resulting suspension or solution to a liquid base composition.
Owner:UNILEVER IP HLDG BV

Application of resveratrol-group piperlongumine analogue in medicine

The invention provides application of a resveratrol group containing piperlongumine analogue in medicine. The structure of the resveratrol-group piperlongumine analogue is as shown in figure (I), and the analogue is obtained on the basis of a great amount of activity screening; the analogue is good in antineoplastic activity; therefore, a new choice is provided for the development and the application of antineoplastic drugs.
Owner:杭州世子合德生物科技有限公司

Application of piperlongumine compound in preparation of medicine for treating schistosomiasis japonicas and medicine composition

The invention provides application of piperlongumine compounds in preparation of drugs for treating schistosomiasis japonicas and a pharmaceutical composition, and belongs to the technical field of drug treatment. Different substituent groups are introduced to the alpha position of Michael double bonds of piperlongumine, the obtained piperlongumine compound has efficient treatment activity on schistosoma japonicum, and the IC50 value of 72-hour in-vitro anti-schistosoma japonicum activity of the piperlongumine compound is 1-5 times that of piperlongumine. Wherein the IC50 value of the 72-hour in-vitro anti-schistosoma japonicum katsurada activity of the compound 9 is equivalent to that of clinical medicine positive control praziquantel.
Owner:GANNAN NORMAL UNIV

Pharmaceutical composition and application thereof in delaying senescence

The invention relates to the technical field of pharmacology, and particularly relates to a pharmaceutical composition and application thereof in delaying senescence. The pharmaceutical composition comprises felinone and piperlongumine, wherein the molar ratio of felinone to piperlongumine is (0.5-2): (1-4). The pharmaceutical composition capable of effectively delaying senescence is found, that is, after felinone and piperlongumine are compounded, drosophila melanogaster is treated, senescence of drosophila melanogaster can be effectively delayed, and the maximum life of drosophila melanogaster is prolonged. The pharmaceutical composition has great significance in the fields of delaying senescence and prolonging the overall life.
Owner:王世宣

Cell freezing medium as well as preparation method and application thereof

The invention discloses a cell freezing medium as well as a preparation method and application thereof. Comprising the following components: an IMDM basal culture medium, DMSO, 4-hydroxyethyl piperazine ethanesulfonic acid, pyridoxal hydrochloride, inositol, putrescine, serotonin, mercaptoethanol, arachidonic acid, cholesterol, catechin, bile alkali chloride, calcium pantothenate, nicotinamide, trehalose, polyoxypropylene polyoxyethylene, Tween 80, albumin, transferrin, fibronectin, fisetin, piperlongumine, tocopheryl acetate and linoleic acid. Linolenic acid, myristic acid, oleic acid, palmitic acid, palmitoleic acid and stearic acid; the composition further comprises amino acids, hormones, inhibitors, cell factors, inorganic compounds and vitamins. The cell cryopreservation liquid provided by the invention is used for cryopreserving mesenchymal stem cells, so that the human umbilical cord mesenchymal stem cells have high survival rate after cryopreservation and resuscitation, and meanwhile, a better differentiation capability is kept; and the cell survival rate and proliferation activity can be better maintained.
Owner:SHENZHEN WINGOR BIO TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products